Interestingly all four genomic subtypes of cutaneous melanoma are associated with aberrant activation of the MAPK and/or PI3K/AKT pathway which supports tumor cell growth, proliferation, survival, and anti-apoptosis signals [15,63]. This evidence concerns the gene AKT1 and neoplasm.